Literature DB >> 21837476

Matrix-induced autologous chondrocyte implantation (MACI) in the knee.

Davide Enea1, Stefano Cecconi, Alberto Busilacchi, Sandra Manzotti, Rosaria Gesuita, Antonio Gigante.   

Abstract

PURPOSE: Matrix-induced autologous chondrocyte implantation (MACI) has been in use for chondral defect repair since 2000, but to date, only little is known about its histological outcomes in the repair of knee cartilage defects. This prospective multicentre study aims to evaluate (1) the quality of the repair tissue obtained from biopsies taken during second-look arthroscopy and (2) the relationship between the histological outcome, the macroscopic appearance of the repair and the patients' functional status.
METHODS: Thirty-three second-look core biopsies from 30 patients treated with MACI were analysed. At the time of biopsy, the surgeon reported the reason for the second-look arthroscopy, the quality of the repair tissue and the patient's functional status on a standardised form. Biopsies together with patient data were sent to our centre to undergo blind histological evaluation and data analysis.
RESULTS: The median overall ICRS II histological score of the examined population was 57 (1st-3rd quartile 41-75). According to the ICRS cartilage repair assessment (CRA) arthroscopic evaluation, 10 biopsies (30%) were classified as normal, 17 (51%) as nearly normal, 4 (12%) as abnormal and 2 (6%) as severely abnormal. The histological outcome was not significantly related either to the macroscopic appearance of the lesion or to the patient's functional status at the time of biopsy.
CONCLUSIONS: In the examined population, the macroscopic appearance of the repair tissue gave an overly favourable impression in comparison with the real histological composition of the tissue, which was possibly still maturing in many cases. The healing process after MACI needs to be better understood through a larger histological study, and a longer follow-up is needed to better clarify the relationship between histology and long-term functional status. LEVEL OF EVIDENCE: IV.

Entities:  

Mesh:

Year:  2011        PMID: 21837476     DOI: 10.1007/s00167-011-1639-1

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  27 in total

1.  Histological evaluation of chondral defects after autologous chondrocyte implantation of the knee.

Authors:  T W R Briggs; S Mahroof; L A David; J Flannelly; J Pringle; M Bayliss
Journal:  J Bone Joint Surg Br       Date:  2003-09

2.  Histological assessment of cartilage repair: a report by the Histology Endpoint Committee of the International Cartilage Repair Society (ICRS).

Authors:  Pierre Mainil-Varlet; Thomas Aigner; Mats Brittberg; Peter Bullough; Anthony Hollander; Ernst Hunziker; Rita Kandel; Stefan Nehrer; Kenneth Pritzker; Sally Roberts; Edouard Stauffer
Journal:  J Bone Joint Surg Am       Date:  2003       Impact factor: 5.284

3.  Autologous chondrocyte implantation in knee joint: MR imaging and histologic features at 1-year follow-up.

Authors:  Bernhard J Tins; Iain W McCall; Tomoki Takahashi; Victor Cassar-Pullicino; Sally Roberts; Brian Ashton; James Richardson
Journal:  Radiology       Date:  2004-12-22       Impact factor: 11.105

4.  Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessment.

Authors:  Ming-Hao Zheng; Craig Willers; Lyn Kirilak; Piers Yates; Jiake Xu; David Wood; Andrew Shimmin
Journal:  Tissue Eng       Date:  2007-04

5.  Autologous chondrocyte transplantation. Biomechanics and long-term durability.

Authors:  Lars Peterson; Mats Brittberg; Illka Kiviranta; Evy Lundgren Akerlund; Anders Lindahl
Journal:  Am J Sports Med       Date:  2002 Jan-Feb       Impact factor: 6.202

6.  Two- to 9-year outcome after autologous chondrocyte transplantation of the knee.

Authors:  L Peterson; T Minas; M Brittberg; A Nilsson; E Sjögren-Jansson; A Lindahl
Journal:  Clin Orthop Relat Res       Date:  2000-05       Impact factor: 4.176

7.  Engineered articular cartilage: influence of the scaffold on cell phenotype and proliferation.

Authors:  Antonio Gigante; Claudia Bevilacqua; Massimo Cappella; Sandra Manzotti; Francesco Greco
Journal:  J Mater Sci Mater Med       Date:  2003-08       Impact factor: 3.896

8.  Autologous chondrocyte implantation using a bilayer collagen membrane: a preliminary report.

Authors:  P Cherubino; F A Grassi; P Bulgheroni; M Ronga
Journal:  J Orthop Surg (Hong Kong)       Date:  2003-06       Impact factor: 1.118

9.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.

Authors:  M Brittberg; A Lindahl; A Nilsson; C Ohlsson; O Isaksson; L Peterson
Journal:  N Engl J Med       Date:  1994-10-06       Impact factor: 91.245

10.  Characteristics of repair tissue in second-look and third-look biopsies from patients treated with engineered cartilage: relationship to symptomatology and time after implantation.

Authors:  Paola Brun; Sally C Dickinson; Barbara Zavan; Roberta Cortivo; Anthony P Hollander; Giovanni Abatangelo
Journal:  Arthritis Res Ther       Date:  2008-11-11       Impact factor: 5.156

View more
  17 in total

1.  Implantation of matrix-induced autologous chondrocyte (MACI ®) grafts using carbon dioxide insufflation arthroscopy.

Authors:  Alberto Vascellari; Enrico Rebuzzi; Stefano Schiavetti; Nicolò Coletti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-01-16       Impact factor: 4.342

2.  Management of cartilage defects in the shoulder.

Authors:  Anthony A Depalma; Konrad I Gruson
Journal:  Curr Rev Musculoskelet Med       Date:  2012-09

Review 3.  Cell-based tissue engineering strategies used in the clinical repair of articular cartilage.

Authors:  Brian J Huang; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Biomaterials       Date:  2016-04-26       Impact factor: 12.479

4.  Short-term follow up after implantation of a cell-free collagen type I matrix for the treatment of large cartilage defects of the knee.

Authors:  Philip P Roessler; Bernhard Pfister; Markus Gesslein; Jens Figiel; Thomas J Heyse; Christian Colcuc; Olaf Lorbach; Turgay Efe; Karl F Schüttler
Journal:  Int Orthop       Date:  2015-02-13       Impact factor: 3.075

5.  Arthroscopic gel-type autologous chondrocyte implantation presents histologic evidence of regenerating hyaline-like cartilage in the knee with articular cartilage defect.

Authors:  Tae-Hwan Yoon; Min Jung; Chong-Hyuk Choi; Hyoung-Sik Kim; Young-Han Lee; Yun-Seok Choi; Sung-Jae Kim; Sung-Hwan Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-06-25       Impact factor: 4.342

6.  Correlation between the quality of cartilage repair tissue and patellofemoral osteoarthritis after matrix-induced autologous chondrocyte implantation at three-year follow-up: a cross-sectional study.

Authors:  Jialing Lyu; Hongli Geng; Weimin Zhu; Dingfu Li; Kang Chen; Hui Ye; Jun Xia
Journal:  Int Orthop       Date:  2022-10-05       Impact factor: 3.479

7.  Matrix-induced autologous chondrocyte implantation (MACI) in the knee: clinical outcomes and challenges.

Authors:  Erhan Basad; Fabian R Wissing; Patrick Fehrenbach; Markus Rickert; Jürgen Steinmeyer; Bernd Ishaque
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-09-14       Impact factor: 4.342

8.  Second-look assessment after all-arthroscopic autologous chondrocyte implantation with spheroides at the knee joint.

Authors:  Rainer Siebold; Georgios Karidakis; Sven Feil; Francis Fernandez
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-24       Impact factor: 4.342

9.  Non-Destructive Spectroscopic Assessment of High and Low Weight Bearing Articular Cartilage Correlates with Mechanical Properties.

Authors:  James P Karchner; Farzad Yousefi; Stephanie R Bitman; Kurosh Darvish; Nancy Pleshko
Journal:  Cartilage       Date:  2018-04-24       Impact factor: 4.634

10.  Matrix assisted autologous chondrocyte transplantation for cartilage treatment: A systematic review.

Authors:  E Kon; G Filardo; B Di Matteo; F Perdisa; M Marcacci
Journal:  Bone Joint Res       Date:  2013-02-01       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.